Ikena Oncology, Inc. (IKNA)

Ikena Oncology Revenue

Ikena Oncology had revenue of $1.84M in the twelve months ending June 30, 2024, down -90.38% year-over-year. In the year 2023, Ikena Oncology had annual revenue of $9.16M, down -41.35%.

• Revenue (ttm): $1.84M
• Revenue Growth: -90.38%
• P/S Ratio: 43.81
• Revenue / Employee: $42,884
• Employees: 43
• Market Cap: 83.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.16M	-6.46M	-41.35%
Dec 31, 2022	15.62M	-15.37M	-49.59%
Dec 31, 2021	30.99M	21.79M	237.01%
Dec 31, 2020	9.19M	-4.56M	-33.15%
Dec 31, 2019	13.75M	12.76M	1,289.19%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.